HISTOLAB PRODUCTS ApS: Financial statements 2020
CVR: 28292090
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
HISTOLAB PRODUCTS ApS (CVR 28292090) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 12,265,249 and a net result of DKK 545,751 compared with DKK 268,799 the year before. That is an increase of 44.6% compared with the year before. The profit margin was 4.4%. Equity in the 2020 report amounted to DKK 2,771,083. The solvency ratio was 52.1%. The company had 1 employee in the financial year.
- Revenue
- DKK 12,265,249
- Gross Profit
- DKK 1,767,348
- Profit/Loss
- DKK 545,751
- Equity
- DKK 2,771,083
- Total Assets
- DKK 5,315,181
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 12.3 mio. | 1.8 mio. | 546 t. | 2.8 mio. | 1 |
| 2019 | 8.5 mio. | 1.3 mio. | 269 t. | 2.2 mio. | 1 |
| 2018 | 8.2 mio. | 1.5 mio. | 375 t. | 2 mio. | 1 |
| 2017 | 7.4 mio. | 1.5 mio. | 415 t. | 1.6 mio. | 1 |
| 2016 | 6.6 mio. | 1.5 mio. | 419 t. | 1.2 mio. | 1 |
Official annual report
How creditworthy is HISTOLAB PRODUCTS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
HISTOLAB PRODUCTS ApS has published its annual report for 2019. Revenue came to DKK 8,483,825, and the net result was DKK 268,799.
About HISTOLAB PRODUCTS ApS
HISTOLAB PRODUCTS ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2004. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named ALGOL PHARMA ApS. The management consists of Caj Patrik Joakim Eurenius. The board consists of Caj Patrik Joakim Eurenius (chair) and Frida Birgitta Ekstrand. The company is owned by Histolab Products AB. The company has 1 employee (2026). In 2025, the company reported revenue of DKK 14,888,720 and a net result of DKK 107,970 compared with DKK 59,499 the year before. Equity in the 2025 report amounted to DKK 3,130,036.